Mendez LC, Dhar A, Laidley D, Moussa M, et al. The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER). BMC Cancer 2023;23:362.
PMID: 37081426